BioMar Group A/S

As of June 30, 2026, BioMar Group A/S carries a market capitalization of 10.52B, placing it among publicly traded companies globally. Its enterprise value stands at 13.71B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

BioMar Group A/S's next confirmed earnings release is scheduled for December 2, 2026.

As of June 30, 2026, BioMar Group A/S has 100.23M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, BioMar Group A/S maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 134.14, indicating elevated leverage, while an interest coverage ratio of 5.76 demonstrates adequate ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 2.43M in revenue per employee across its workforce of 1,712.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, BioMar Group A/S recorded 60.00M in income tax expense. That works out to an effective tax rate of 27.52, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

As of the close on October 22, 2026, BioMar Group A/S's stock has declined approximately 29.62% over the past 52 weeks. The 50-day moving average sits at 126.78, while the 200-day moving average is 149.24.

These figures cover the twelve months ended June 30, 2026.

As of June 30, 2026, BioMar Group A/S holds 563.00M in cash and equivalents against 3.75B in total debt, resulting in a net debt position of 3.19B. Total book value stands at 2.79B, with working capital of 428.00M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026. After subtracting -127.00M in capital expenditures, free cash flow totaled 69.00M - equivalent to 0.69 per share.

Over the twelve months ended June 30, 2026, BioMar Group A/S posted a gross margin of 22.89, reflecting its pricing power and cost economics. The operating margin of 5.98 and net profit margin of 3.84 provide insight into operational efficiency.